2026 Miami Cancer Institute Precision Oncology Symposium Evaluation - Day 2

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients.	The skills learned in this CME course will be applied in the treatment of my patients. - 5	The skills learned in this CME course will be applied in the treatment of my patients. - 4	The skills learned in this CME course will be applied in the treatment of my patients. - 3	The skills learned in this CME course will be applied in the treatment of my patients. - 2	The skills learned in this CME course will be applied in the treatment of my patients. - 1	The skills learned in this CME course will be applied in the treatment of my patients. - NA

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence NA|Not applicable to my practice

	5	4	3	2	1
Properly diagnose and manage solid tumor malignancies.	Properly diagnose and manage solid tumor malignancies. - 5	Properly diagnose and manage solid tumor malignancies. - 4	Properly diagnose and manage solid tumor malignancies. - 3	Properly diagnose and manage solid tumor malignancies. - 2	Properly diagnose and manage solid tumor malignancies. - 1
Provide an update of new molecular and targeted treatments being developed for solid tumors.	Provide an update of new molecular and targeted treatments being developed for solid tumors. - 5	Provide an update of new molecular and targeted treatments being developed for solid tumors. - 4	Provide an update of new molecular and targeted treatments being developed for solid tumors. - 3	Provide an update of new molecular and targeted treatments being developed for solid tumors. - 2	Provide an update of new molecular and targeted treatments being developed for solid tumors. - 1

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Urothelial Cancer - Petros Grivas, M.D.	Urothelial Cancer - Petros Grivas, M.D. - 5	Urothelial Cancer - Petros Grivas, M.D. - 4	Urothelial Cancer - Petros Grivas, M.D. - 3	Urothelial Cancer - Petros Grivas, M.D. - 2	Urothelial Cancer - Petros Grivas, M.D. - 1
Breaking Barriers: Precision Medicine Strategies for Breast Cancer Brain Metastases - Nancy Lin, M.D.	Breaking Barriers: Precision Medicine Strategies for Breast Cancer Brain Metastases - Nancy Lin, M.D. - 5	Breaking Barriers: Precision Medicine Strategies for Breast Cancer Brain Metastases - Nancy Lin, M.D. - 4	Breaking Barriers: Precision Medicine Strategies for Breast Cancer Brain Metastases - Nancy Lin, M.D. - 3	Breaking Barriers: Precision Medicine Strategies for Breast Cancer Brain Metastases - Nancy Lin, M.D. - 2	Breaking Barriers: Precision Medicine Strategies for Breast Cancer Brain Metastases - Nancy Lin, M.D. - 1
Precision Medicine Strategies for Brain Metastases - Manmeet Ahluwalia, M.D.	Precision Medicine Strategies for Brain Metastases - Manmeet Ahluwalia, M.D. - 5	Precision Medicine Strategies for Brain Metastases - Manmeet Ahluwalia, M.D. - 4	Precision Medicine Strategies for Brain Metastases - Manmeet Ahluwalia, M.D. - 3	Precision Medicine Strategies for Brain Metastases - Manmeet Ahluwalia, M.D. - 2	Precision Medicine Strategies for Brain Metastases - Manmeet Ahluwalia, M.D. - 1
ASCO's Journey of Precision Medicine - Julie Gralow, M.D.	ASCO's Journey of Precision Medicine - Julie Gralow, M.D. - 5	ASCO's Journey of Precision Medicine - Julie Gralow, M.D. - 4	ASCO's Journey of Precision Medicine - Julie Gralow, M.D. - 3	ASCO's Journey of Precision Medicine - Julie Gralow, M.D. - 2	ASCO's Journey of Precision Medicine - Julie Gralow, M.D. - 1
Precision Oncology Approaches in Uncommon Mutations in Lung Cancer - Bruna Pellini, M.D.	Precision Oncology Approaches in Uncommon Mutations in Lung Cancer - Bruna Pellini, M.D. - 5	Precision Oncology Approaches in Uncommon Mutations in Lung Cancer - Bruna Pellini, M.D. - 4	Precision Oncology Approaches in Uncommon Mutations in Lung Cancer - Bruna Pellini, M.D. - 3	Precision Oncology Approaches in Uncommon Mutations in Lung Cancer - Bruna Pellini, M.D. - 2	Precision Oncology Approaches in Uncommon Mutations in Lung Cancer - Bruna Pellini, M.D. - 1
Precision Oncology Approaches in Common Mutations in Lung Cancer - Vamsi Velcheti, M.D.	Precision Oncology Approaches in Common Mutations in Lung Cancer - Vamsi Velcheti, M.D. - 5	Precision Oncology Approaches in Common Mutations in Lung Cancer - Vamsi Velcheti, M.D. - 4	Precision Oncology Approaches in Common Mutations in Lung Cancer - Vamsi Velcheti, M.D. - 3	Precision Oncology Approaches in Common Mutations in Lung Cancer - Vamsi Velcheti, M.D. - 2	Precision Oncology Approaches in Common Mutations in Lung Cancer - Vamsi Velcheti, M.D. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

As a result of my participation in this Symposium, I commit to make the following changes to my clinical practice: *

I will analyze evolving therapeutic strategies in the treatment of solid tumor malignancies and use this knowledge to inform my clinical decision-making.

I will evaluate new molecular and targeted treatments being developed for solid tumor malignancies and consider their relevance to my practice.

I will apply the rationale for targeted diagnostic and therapeutic strategies across lung, breast, gastrointestinal, genitourinary, head and neck, melanoma, sarcoma, and brain tumors when planning patient care.

I will assess the role and timing of diagnostic tests, molecular profiling, and potential combinations of targeted therapies to guide personalized treatment strategies for my patients.

Not applicable to my practice.

I am retired.

I have not implemented any strategies.

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

Name

You are here

2026 Miami Cancer Institute Precision Oncology Symposium Evaluation - Day 2